Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma

G. Schwefel (Rostock, Germany), K. Bratke (Rostock, Germany), H. Marchewski (Rostock, Germany), J. Virchow (Rostock, Germany), M. Lommatzsch (Rostock, Germany)

Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Session: Precision meets immunology in treatment of airway diseases
Session type: Oral Presentation
Number: 3801

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Schwefel (Rostock, Germany), K. Bratke (Rostock, Germany), H. Marchewski (Rostock, Germany), J. Virchow (Rostock, Germany), M. Lommatzsch (Rostock, Germany). Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma. 3801

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: